Dividends aren't just about the money. Sure, it's great to have a little more when companies ramp up their payouts, but it's also a fair sign that a company feels confident about increasing its cash flow in the future. Stocks that boost their dividends make an interesting pool of income-producing investing opportunities with the added potential for a capital-appreciation kicker.
Let's take a closer look at four of the companies that inched their payouts higher this past week.
Remember when Microsoft
Financially speaking, Pfizer is in better shape than many of the other fallen big pharma names, such as Merck
Then we have T. Rowe Price
Subscribers to our Motley Fool Income Investor newsletter can appreciate companies sending more and more money to their investors. Analyst Mathew Emmert has often singled out companies that are committed to growing their distributions with market-thumping results.
Want to see what Mathew's liking these days? Go ahead and give his newsletter service a shot with a 30-day trial subscription. Who knows? Maybe the next thing that will get hiked will be your interest.
Merck is a Motley Fool Income Investor recommendation.
Longtime Fool contributor Rick Munarriz pays attention to yield signs. He does not own shares in any of the companies mentioned in this story. The Fool has a disclosure policy. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.